Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ying-Shan Chung"'
Publikováno v:
OncoTargets and Therapy. 15:1573-1582
Meng-Chin Ho,1 Ying-Shan Chung,2,3 Yu-Ching Lin,1,4 Ming-Szu Hung,1,4,5 Yu-Hung Fang1,3 1Division of Thoracic Oncology, Department of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital, Puzi City, Chiayi County, Taiwan, Republic of Ch
Publikováno v:
OncoTargets and Therapy. 15:1563-1571
Ying-Shan Chung,1,2 Yu-Ching Lin,3,4 Ming-Szu Hung,3â 5 Meng-Chin Ho,3 Yu-Hung Fang2,3 1Department of Pharmacy, Chang Gung Memorial Hospital, Puzi City, Taiwan, Republic of China; 2Department of Nursing, Chang Gung University of Science and Tech
Publikováno v:
OncoTargets and therapy. 15
Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKIs)-associatedWe conducted a retrospective cohort study using multi-institutional electronic medical records database. We included patients aged older than 20 years diagnosed with lun
Autor:
Ying Shan Chung, Swu Jane Lin, Yea Huei Kao Yang, Shih Chieh Shao, Yen Kuang Yang, Mei Hong Chi, Chien Chou Su, Edward Chia Cheng Lai
Publikováno v:
European Child & Adolescent Psychiatry. 30:769-783
Understanding different cardiometabolic safety profiles of antipsychotics helps avoid unintended outcomes among young patients. We conducted a population-based study to compare cardiometabolic risk among different antipsychotics in children, adolesce
Autor:
Ying-Shan, Chung, Shih-Chieh, Shao, Mei-Hong, Chi, Swu-Jane, Lin, Chien-Chou, Su, Yea-Huei, Kao Yang, Yen-Kuang, Yang, Edward Chia-Cheng, Lai
Publikováno v:
European childadolescent psychiatry. 30(5)
Understanding different cardiometabolic safety profiles of antipsychotics helps avoid unintended outcomes among young patients. We conducted a population-based study to compare cardiometabolic risk among different antipsychotics in children, adolesce